TABLE 1.
Effects of methylation levels in the CpG sites of the EXO1 gene on the prognosis of HCC patients.
| CpG island | HR | p-value |
|---|---|---|
| TSS1500; TSS200-Island-cg00309178 | 1.397 | 0.11 |
| Body-Open_Sea-cg03116938 | 2.104 | 0.0023 |
| TSS1500-N_Shore-cg03292648 | 0.548 | 0.0007 |
| TSS1500; TSS200-Island-cg04158730 | 1.17 | 0.38 |
| TSS1500-N_Shore-cg06713297 | 1.163 | 0.4 |
| TSS1500-Island-cg07639959 | 0.808 | 0.29 |
| Body-Open_Sea-cg11837910 | 1.855 | 0.0025 |
| TSS1500; 5′UTR; 1stExon-Island-cg12401425 | 1.458 | 0.079 |
| TSS1500-Island-cg17423498 | 1.39 | 0.06 |
| TSS1500; TSS200-Island-cg17736920 | 0.832 | 0.3 |
| TSS1500; 5′UTR; 1stExon-Island-cg20629097 | 1.147 | 0.43 |
| TSS1500; TSS200-Island-cg21919602 | 1.547 | 0.013 |
| Body;3′UTR-Open_Sea-cg22022181 | 2.375 | 0.00052 |
| TSS1500;5′UTR-Island-cg24741598 | 1.662 | 0.03 |
HCC, hepatocellular carcinoma; HR, hazard ratio.